AOD-9604 Peptide 5mg – Lyophilized Research Peptide

Product Overview

AOD-9604 Peptide 5mg is a research peptide supplied in lyophilized powder form for laboratory research and analytical applications. Global Peptides Lab provides detailed product specifications and batch-specific analytical information to help research professionals evaluate the material they are considering for their work.

AOD-9604 is a synthetic peptide fragment derived from a region of human growth hormone (hGH). It has been investigated in scientific research concerning metabolism, fat metabolism pathways, and biological processes associated with energy regulation. Its research history has attracted scientific interest in understanding how specific peptide fragments interact with biological systems.

This product is supplied as a dry powder in a 7 mL (6R) vial. It is not reconstituted, and the stated 5 mg strength refers to the nominal product quantity. The accompanying batch results report the measured sample weight separately, allowing buyers to distinguish the product specification from the analytical measurement.

At Global Peptides Lab, clear product information and transparent presentation of available test results are important parts of responsible research-material sourcing.

AOD-9604 Research Background

AOD-9604 was developed as a modified fragment of human growth hormone. Researchers have studied this peptide to better understand whether selected biological activities associated with growth hormone could be investigated independently of the hormone’s broader effects.

Scientific interest has included laboratory and clinical investigations related to fat metabolism and body-weight regulation. However, research findings must be interpreted carefully. Results from an experimental model do not automatically establish that a substance produces the same effect in humans.

Although AOD-9604 has been discussed in connection with weight management and fat-loss research, these descriptions should not be interpreted as proof of effectiveness, safety, or suitability for treating obesity. The available evidence does not establish it as an approved weight-loss treatment.

For this reason, the material offered on this page is presented as a research product rather than as a medicine, dietary supplement, or consumer weight-management solution.

Product Specifications

The following specifications describe the supplied material and the reported analytical results for the identified batch.

• Product name: AOD-9604 Peptide
• Nominal product quantity: 5 mg
• Product form: Lyophilized powder
• Container: Vial
• Vial size: 7 mL (6R)
• Reconstitution status: Not reconstituted
• Batch number: AOD06260905I
• Date tested: June 12, 2026

Reported Batch Test Results

The supplied test information includes three quality-related measurements:

Test parameter	Reported result
Purity	99.883%
Sample weight	5.33 mg
Endotoxins (LPS)	Pass

These values relate to the identified batch and should be interpreted according to the applicable analytical methods and the original laboratory documentation.

Understanding the Purity Result

The reported purity of 99.883% represents the result provided for the tested batch. Purity testing helps characterize the composition of a sample under a specified analytical method. It does not, by itself, establish identity, biological activity, sterility, or suitability for human administration.

Researchers should review the underlying analytical report for information about the method used, the reference standard, and any relevant limitations.

Understanding the Weight Result

The reported measured weight is 5.33 mg, while the product is named and listed at a nominal strength of 5 mg. These are separate pieces of information and should not be treated as interchangeable.

The measured weight should be understood in the context of the original test report, including how the sample was weighed and whether the reported value represents net material, a tested aliquot, or another measurement.

Understanding the Endotoxin Result

The reported endotoxin result is “Pass” for the listed batch. Endotoxins, including lipopolysaccharides (LPS), are substances associated with certain bacteria and can be relevant to laboratory material characterization.

An endotoxin test result should be interpreted alongside the test method, acceptance criteria, and supporting documentation. A passing result alone does not establish that a product is sterile or safe for injection.

Product Form and Packaging

This material is supplied as a lyophilized powder in a 7 mL (6R) vial. Lyophilization is a freeze-drying process used to remove water from a material under controlled conditions. It can help support the storage of certain laboratory materials in a dry form.

The vial is supplied without reconstitution. No liquid preparation is included in the stated product configuration.

Researchers should consult the supplier’s applicable documentation for verified storage conditions, handling requirements, and any material-specific limitations. Avoid assuming a particular storage temperature or shelf life unless it is supported by the product documentation.

Why Batch-Specific Information Matters

When comparing research materials, a product name and nominal quantity provide only part of the picture. Batch identification and analytical results can help researchers connect a product to the available quality documentation.

For this product, the batch number AOD06260905I identifies the batch associated with the test information supplied above. The reported purity, measured weight, and endotoxin result should be reviewed together with the original test report.

Before making a purchasing decision, qualified research personnel should assess whether the available documentation meets their study requirements. If a particular analytical method, identity confirmation, or additional quality test is essential, verify its availability rather than assuming it has been performed.

Frequently Asked Questions

What is AOD-9604?

AOD-9604 is a synthetic peptide fragment derived from human growth hormone that has been investigated in research involving metabolism and fat-related biological processes. Research interest does not establish clinical effectiveness or approval for a medical use.

What form does this product come in?

The product is supplied as lyophilized powder in a 7 mL (6R) vial. It is not reconstituted.

What is the reported purity?

The supplied batch test information reports a purity of 99.883% for batch AOD06260905I, tested on June 12, 2026. Consult the original analytical report for the method and interpretation.

Why does the listed strength differ from the measured weight?

The product has a nominal quantity of 5 mg, while the supplied test result states a measured weight of 5.33 mg. The figures describe different reported specifications and should be interpreted using the original test documentation.

Does the endotoxin result mean the product is sterile?

No. A reported endotoxin test pass does not establish sterility. Sterility and endotoxin testing address different quality considerations.

Is this product an approved weight-loss treatment?

This listing does not establish AOD-9604 as an approved weight-loss medicine. It should not be represented as a proven treatment for obesity or as a product guaranteed to cause fat loss.

Is the product intended for human use?

No. This product is presented for laboratory research purposes only and is not intended for human or veterinary use.

Order Research Materials from Global Peptides Lab

Global Peptides Lab aims to provide clear product specifications and available batch information for research-material evaluation. Review the listed formulation, nominal quantity, container details, and reported analytical results before making a purchasing decision.

For questions about the available batch documentation or product specifications, contact Global Peptides Lab before ordering. Researchers should use appropriate institutional procedures and applicable regulations when sourcing and handling research materials.

Research-use notice: This product is not intended for human consumption, self-administration, diagnosis, treatment, cure, or prevention of any disease. No claim of clinical safety or effectiveness is made.